LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Beckman Coulter Unveils New DxI 9000 Access Immunoassay Analyzer

By LabMedica International staff writers
Posted on 24 May 2023
Image: The DxI 9000 Access immunoassay analyzer enables elite laboratory performance with no daily maintenance (Photo courtesy of Beckman Coulter)
Image: The DxI 9000 Access immunoassay analyzer enables elite laboratory performance with no daily maintenance (Photo courtesy of Beckman Coulter)

The 25th WorldLab-EuroMedLab Congress will see the global unveiling of a brand-new high throughput immunoassay analyzer by Beckman Coulter, Inc. (Brea, CA, USA).

Visitors to the Beckman Coulter at EuroMedLab 2023 will get a first look at the new DxI 9000 Access immunoassay analyzer that is designed for superior laboratory performance and demands no daily maintenance. The DxI 9000 is the most efficient immunoassay analyzer in terms of footprint, boasting the ability to process up to 215 tests per hour per square meter (tests/hr/m2). The DxI 9000 Analyzer’s cutting-edge features cater to the current demands for speed, reliability, consistency, quality, and menu expansion. Its unique ZeroDaily Maintenance feature further enhances the device's uptime performance, as confirmed by beta users who report that it redefines their workday by eliminating daily maintenance tasks and reducing yearly maintenance routines by up to a staggering 96%.

The DxI 9000 Analyzer is equipped with the state-of-the-art PrecisionVision Technology, capable of scrutinizing, identifying, and preventing inaccurate reporting in real-time. Beckman Coulter's newly-introduced remote service and diagnostic solution, DxS IntelliServe, connects with DxI 9000 Analyzers, keeping track of data and error patterns, and facilitating proactive system servicing when necessary. Additionally, Beckman Coulter is presenting educational workshops on three subject areas – ‘Intelligent automation for laboratories of all sizes’, ‘Creating a culture of innovation in your laboratory’ and ‘Early recognition of severe infection and risk of sepsis’.

Related Links:
Beckman Coulter, Inc.

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sample Transportation System
Tempus1800 Necto
ESR Analyzer
TEST1 2.0

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more